Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:135-144
doi: 10.1161/01.CIR.0000155618.37779.A0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuster, V.
Right arrow Articles by Kim, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuster, V.
Right arrow Articles by Kim, R. J.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Pathophysiology
Right arrow Other diagnostic testing
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Other Vascular biology

(Circulation. 2005;112:135-144.)
© 2005 American Heart Association, Inc.


New Drugs and Technologies

Frontiers in Cardiovascular Magnetic Resonance

Valentin Fuster, MD, PhD; Raymond J. Kim, MD

From the Zena and Michael A. Wiener Cardiovascular Institute and The Marie-Josee and Henry R. Kravis Cardiovascular Health Center (V.F.), The Mount Sinai School of Medicine, New York, NY, and Duke Cardiovascular Magnetic Resonance Center (R.J.K.), Duke University Medical Center, Durham, NC.

Correspondence to Raymond J. Kim, MD, Duke Cardiovascular MRI Center, DUMC-3934, Durham, NC 27710 (e-mail Raymond.Kim@dcmrc.mc.duke.edu), or Valentin Fuster, MD, PhD, Mount Sinai School of Medicine, Box 1030, New York, NY 10029 (e-mail valentin.fuster@mssm.edu).


Key Words: magnetic resonance imaging • atherosclerosis • myocardial infarction • coronary disease • vasculature


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Cardiovascular magnetic resonance (MR) is emerging as a multipurpose imaging modality for the assessment of cardiovascular disease in general and ischemic heart disease in particular. Currently, the pace of innovation is rapid, and the modality is changing from one that is used primarily as a research tool to one that is increasingly used in routine clinical practice. The process of innovation includes not only improvements in scanner hardware, such as coil and gradient technology, and the development of new contrast agents but also the development of novel pulse sequences. The concept of the pulse sequence, in which programming changes at the scanner can lead to fundamental changes in activating tissue, is unique to MR and gives this modality the potential to assess a vast number of biological parameters.

Cardiovascular MR promises to play an important clinical and investigational role in both vascular and cardiac systems. Current and potential future applications of cardiovascular MR will be discussed with a particular focus on ischemic heart disease. Multidetector-row computed tomography, another promising and complementary noninvasive imaging technology, will be discussed briefly in relation to cardiovascular MR for the assessment of atherothrombotic disease.


*    The Vasculature and Atherothrombotic Disease
 
Nomenclature and Evolving Imaging Assessment
Atherothrombosis is a systemic or multiterritory arterial disease that primarily affects the large- and medium systemic arteries, including the aorta and the carotid, coronary, and peripheral arteries. Although the epicardial coronary arteries appear to be the most susceptible to atherothrombosis,1,2 intramyocardial arteries are relatively resistant. The concept of multiterritory atherothrombosis has been addressed in 2 large studies of symptomatic patients that . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
A. Cassar, D. R. Holmes Jr, C. S. Rihal, and B. J. Gersh
Chronic Coronary Artery Disease: Diagnosis and Management
Mayo Clin. Proc., December 1, 2009; 84(12): 1130 - 1146.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. Bruder, S. Schneider, D. Nothnagel, T. Dill, V. Hombach, J. Schulz-Menger, E. Nagel, M. Lombardi, A. C. van Rossum, A. Wagner, et al.
EuroCMR (European Cardiovascular Magnetic Resonance) Registry: Results of the German Pilot Phase
J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1457 - 1466.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
P. G. Chan, M. P. Smith, T. H. Hauser, S. B. Yeon, E. Appelbaum, N. M. Rofsky, and W. J. Manning
Noncardiac Pathology on Clinical Cardiac Magnetic Resonance Imaging
J. Am. Coll. Cardiol. Img., August 1, 2009; 2(8): 980 - 986.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. S. Jaffe
Key Issues in the Developing Synergism between Cardiovascular Imaging and Biomarkers
Clin. Chem., September 1, 2008; 54(9): 1432 - 1442.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Nahrendorf, D. Sosnovik, J. W. Chen, P. Panizzi, J.-L. Figueiredo, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder
Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury
Circulation, March 4, 2008; 117(9): 1153 - 1160.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. A. Jaffer, P. Libby, and R. Weissleder
Molecular Imaging of Cardiovascular Disease
Circulation, August 28, 2007; 116(9): 1052 - 1061.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726.
[Full Text] [PDF]


Home page
CirculationHome page
B. Sievers, M. D. Elliott, L. M. Hurwitz, T. S.E. Albert, I. Klem, W. G. Rehwald, M. A. Parker, R. M. Judd, and R. J. Kim
Rapid Detection of Myocardial Infarction by Subsecond, Free-Breathing Delayed Contrast-Enhancement Cardiovascular Magnetic Resonance
Circulation, January 16, 2007; 115(2): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Porto, J. B. Selvanayagam, W. J. Van Gaal, F. Prati, A. Cheng, K. Channon, S. Neubauer, and A. P. Banning
Plaque Volume and Occurrence and Location of Periprocedural Myocardial Necrosis After Percutaneous Coronary Intervention: Insights From Delayed-Enhancement Magnetic Resonance Imaging, Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade Analysis, and Intravascular Ultrasound
Circulation, August 15, 2006; 114(7): 662 - 669.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Klem, J. F. Heitner, D. J. Shah, M. H. Sketch Jr, V. Behar, J. Weinsaft, P. Cawley, M. Parker, M. Elliott, R. M. Judd, et al.
Improved Detection of Coronary Artery Disease by Stress Perfusion Cardiovascular Magnetic Resonance With the Use of Delayed Enhancement Infarction Imaging
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1630 - 1638.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. L. Ruberg, J. Viereck, A. Phinikaridou, Y. Qiao, J. Loscalzo, and J. A. Hamilton
Identification of cholesteryl esters in human carotid atherosclerosis by ex vivo image-guided proton MRS
J. Lipid Res., February 1, 2006; 47(2): 310 - 317.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, Z. A. Fayad, P. R. Moreno, M. Poon, R. Corti, and J. J. Badimon
Atherothrombosis and High-Risk Plaque: Part II: Approaches by Noninvasive Computed Tomographic/Magnetic Resonance Imaging
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1209 - 1218.
[Abstract] [Full Text] [PDF]